Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2023 08:00 ET | Source: iCAD, Inc.

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast...
November 20, 2023 08:00 ET | Source: iCAD, Inc.

iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution

Offering radiology the most complete breast health solution, including breast density assessment, breast cancer detection, and thorough risk evaluation, including lifetime, genetic, and short-term 1-...
November 14, 2023 08:00 ET | Source: iCAD, Inc.

iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
November 13, 2023 16:01 ET | Source: iCAD, Inc.

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
October 30, 2023 08:00 ET | Source: iCAD, Inc.

iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023

NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
October 23, 2023 08:01 ET | Source: iCAD, Inc.

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

NASHUA, N.H., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announced today that Elekta...
August 16, 2023 08:00 ET | Source: iCAD, Inc.

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health...
August 14, 2023 16:01 ET | Source: iCAD, Inc.

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023

NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its...
August 14, 2023 08:00 ET | Source: iCAD, Inc.

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed...
July 31, 2023 08:00 ET | Source: iCAD, Inc.

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

NASHUA, N.H., July 31, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right